In assisted reproduction, there are many terms that may be more or less familiar. Most people have heard, to some extent, of concepts such as the embryo or the endometrium. However, there are other “key players” that, although less well known, are no less important. This is the case of the blastocyst, a natural and fundamental stage of embryonic development, whose understanding is essential to explain why fertility treatments today achieve increasingly high success rates.
The sperm cell fertilizes the egg, giving rise to what we know as an embryo, which begins to divide and multiply its cells during the first days of development. Around the fifth or sixth day, the embryo reaches a crucial point in its development: the blastocyst stage. At this moment, the embryo has progressed from being a group of similar cells to becoming an organized structure with different cell types and specialized functions.
The blastocyst is composed of two main parts. On the one hand, the inner cell mass, which will give rise to the future baby, and on the other, the trophectoderm, which will form the placenta and the membranes that protect the embryo. Between these two structures lies a fluid-filled cavity known as the blastocoel, which gives the blastocyst its characteristic spherical shape. It is precisely at this stage that the embryo prepares for implantation in the uterus.

The terms embryo and blastocyst are often used interchangeably, although they are not exactly the same. In reality, the blastocyst represents a more advanced and complex stage of embryonic development. During the first days after fertilization, the embryo consists of only a few identical cells, without a defined structure. By contrast, once it reaches the blastocyst stage, the first major cellular differentiation has already occurred—an essential step that reflects a greater potential for implantation and successful development.
This difference has important clinical implications. In many cases, it allows certain embryos to be ruled out in the laboratory, as embryologists can identify those with a higher potential to result in pregnancy, although this does not guarantee the outcome with absolute certainty.
Advances in technology have enabled laboratories to adopt new tools that improve embryo culture up to the blastocyst stage and the selection of the most viable embryos. Advanced observation systems, such as time-lapse incubators, make it possible to record the development of each embryo in real time without removing it from its controlled environment.
At the same time, the use of artificial intelligence in the analysis of embryonic images is opening new avenues to improve selection accuracy. These tools allow specialists to base their decisions on objective and reproducible criteria, which may translate into more precise selection and, in some cases, higher implantation and pregnancy rates.

It is important to understand that not all embryos reach the blastocyst stage, and this is completely normal. Of the fertilized eggs obtained in an IVF cycle, only about 30% to 50% reach this stage. This percentage may vary depending on maternal age, egg quality, and other clinical factors, mainly because embryonic development is a highly demanding process and only embryos with a balanced genetic and metabolic profile are able to progress to day five or six.
For this reason, the decision to perform blastocyst culture depends on the characteristics of each individual case, such as the number of eggs retrieved, their quality, maternal age, and reproductive history. All these factors are carefully evaluated by the medical team before choosing this strategy.
Transferring embryos that have reached the blastocyst stage offers clear advantages in assisted reproduction treatments. In these cases, there is greater synchrony with the endometrium, as the transfer is carried out at the same time that, under natural conditions, an embryo would implant in the uterus. In addition, since these embryos have successfully passed the earliest stages of development, they tend to show higher biological potential, allowing fewer embryos to be transferred and reducing the risk of multiple pregnancies.
Another advantage of blastocyst culture is improved selection. Embryologists can observe embryo development over several days and more accurately assess which embryos are best suited for transfer or freezing for future use. Thanks to these techniques, treatment planning becomes more flexible and the chances of success may improve.
Working with blastocysts has represented a major advance in assisted reproduction. Compared with transfers performed at earlier stages, the ability to observe embryonic development up to day five or six has made it possible to better understand the mechanisms of natural selection that occur in the laboratory and to reproduce them in a controlled manner.
Today, blastocysts represent not only a biological stage of the embryo but also a key medical tool that allows fertility treatments to be personalized and the chances of implantation and pregnancy to be optimized.